DSCAM and breast cancer: miR-137 can prompt cell cycle arrest at the G0/G1 phase, so its suppression by DSCAM-AS1 leads to enhancement of cell reproduction and inhibition of cell apoptosis in tamoxifen resistant breast cancer cells (Ma et al., 2019).